![NMD pulls in $40M from Jeito-led, Roche-backed syndicate, gaining financial muscle to crack myasthenia gravis market | Fierce Biotech NMD pulls in $40M from Jeito-led, Roche-backed syndicate, gaining financial muscle to crack myasthenia gravis market | Fierce Biotech](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1641490642/GettyImages-866149824%20%281%29.jpg/GettyImages-866149824%20%281%29.jpg?VersionId=lm.pi47bTRA.WNeogYiEG7XzDbOWaYme)
NMD pulls in $40M from Jeito-led, Roche-backed syndicate, gaining financial muscle to crack myasthenia gravis market | Fierce Biotech
![NMD Pharma on Twitter: "Dr @DaveArnoldLab, a professor at @OhioState and a close collaborator with #NMDPharma on both #CMT and #Sarcopenia observational studies is currently visiting the NMD Pharma team in #Aarhus. NMD Pharma on Twitter: "Dr @DaveArnoldLab, a professor at @OhioState and a close collaborator with #NMDPharma on both #CMT and #Sarcopenia observational studies is currently visiting the NMD Pharma team in #Aarhus.](https://pbs.twimg.com/media/FPKyo2zWYAMf0hD.jpg)
NMD Pharma on Twitter: "Dr @DaveArnoldLab, a professor at @OhioState and a close collaborator with #NMDPharma on both #CMT and #Sarcopenia observational studies is currently visiting the NMD Pharma team in #Aarhus.
![NMD Pharma on Twitter: "We are thrilled to announce the opening of our new office in the US. We look forward to expanding the team across the Atlantic and be part of NMD Pharma on Twitter: "We are thrilled to announce the opening of our new office in the US. We look forward to expanding the team across the Atlantic and be part of](https://pbs.twimg.com/media/FR1UgP5XIAI55Hb.jpg)
NMD Pharma on Twitter: "We are thrilled to announce the opening of our new office in the US. We look forward to expanding the team across the Atlantic and be part of
![Following a compound from start to finish - Nordic Life Science – the leading Nordic life science news service Following a compound from start to finish - Nordic Life Science – the leading Nordic life science news service](https://nordiclifescience.org/wp-content/public_html/2022/07/2021-03-08-NMD-2238-e1657558866597-760x380.jpg)
Following a compound from start to finish - Nordic Life Science – the leading Nordic life science news service
![Following a compound from start to finish - Nordic Life Science – the leading Nordic life science news service Following a compound from start to finish - Nordic Life Science – the leading Nordic life science news service](https://nordiclifescience.org/wp-content/public_html/2022/07/2021-03-08-NMD-2179-e1657559167768.jpg)
Following a compound from start to finish - Nordic Life Science – the leading Nordic life science news service
![adidas NMD_R1 TR Shoes - Orange | Men's Lifestyle | adidas US in 2022 | Adidas shoes nmd, Adidas nmd, Adidas nmd r1 adidas NMD_R1 TR Shoes - Orange | Men's Lifestyle | adidas US in 2022 | Adidas shoes nmd, Adidas nmd, Adidas nmd r1](https://i.pinimg.com/originals/28/b2/49/28b2490b4a5857b3feb69813b49c0641.jpg)
adidas NMD_R1 TR Shoes - Orange | Men's Lifestyle | adidas US in 2022 | Adidas shoes nmd, Adidas nmd, Adidas nmd r1
![Jeito Capital Becomes Key Investor in NMD Pharma as Part of a €35 Million New Financing | Business Wire Jeito Capital Becomes Key Investor in NMD Pharma as Part of a €35 Million New Financing | Business Wire](https://mms.businesswire.com/media/20220214005583/en/1358538/22/JEITO-04_%281%29.jpg)